| JXHL2100034 | ABBV-744片 | ABBV-744 | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-02-03 | AbbVie Inc. | Abbvie Inc | In Review | 2021-02-03 | view |
| JXHL2100037 | Navitoclax片 | navitoclax | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-02-03 | AbbVie Inc. | Abbvie Inc | In Review | 2021-02-03 | view |
| JXHL2100036 | Navitoclax片 | navitoclax | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-02-03 | AbbVie Inc. | Abbvie Inc | In Review | 2021-02-03 | view |
| JXHL2100035 | ABBV-744片 | ABBV-744 | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-02-03 | AbbVie Inc. | Abbvie Inc | In Review | 2021-02-03 | view |
| JXSB2000054 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-25 | AbbVie Inc. | Abbvie Inc | In Review | 2021-05-09 | view |
| JXSB2000055 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-25 | AbbVie Inc. | Abbvie Inc | In Review | 2021-05-09 | view |
| JXSL2000219 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-12-10 | AbbVie Inc. | Abbvie Inc | In Review | 2020-12-09 | view |
| JXSL2000218 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Import Drug Application | 2020-12-10 | AbbVie Inc. | Abbvie Inc | In Review | 2020-12-09 | view |
| JXHL2000263 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-23 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-22 | view |
| JXHL2000262 | Upadacitinib片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-09-23 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-22 | view |
| JXHL2000261 | Elsubrutinib(ABBV-105)胶囊 | elsubrutinib | Capsule | Chemical Drugs(1) | Import Drug Application | 2020-09-23 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-22 | view |
| JXHB2000023 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-09-04 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-03 | view |
| JXHB2000022 | ABT-494片 | upadacitinib | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-09-04 | AbbVie Inc. | Abbvie Inc | In Review | 2020-09-03 | view |
| JYHB2001571 | 洛匹那韦/利托那韦口服溶液 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2020-08-25 | AbbVie Inc | Abbvie Inc | Certificate Issued | 2021-02-25 | view |
| JXHL2000184 | Venetoclax片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-07-06 | AbbVie Inc. | Abbvie Inc | In Review | 2020-07-04 | view |
| JXHL2000186 | Venetoclax片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-07-06 | AbbVie Inc. | Abbvie Inc | In Review | 2020-07-04 | view |
| JXHL2000185 | Venetoclax片 | Venetoclax | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-07-06 | AbbVie Inc. | Abbvie Inc | In Review | 2020-07-04 | view |
| JYHB2000636 | 洛匹那韦/利托那韦口服溶液 | lopinavir;ritonavir | Oral solution | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Inc | Abbvie Inc | Filed | 2020-06-09 | view |
| JXHS2000003 | 维奈克拉片 | Venetoclax | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-01-13 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2020-12-08 | view |
| JXHS2000002 | 维奈克拉片 | Venetoclax | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-01-13 | AbbVie Inc. | Abbvie Inc | Certificate Issued | 2020-12-08 | view |
